Expression of imp1 enhances production of murine leukemia virus vector by facilitating viral genomic RNA packaging

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Mai, Yun ^a   Gao, Guangxia ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INSULIN LIKE GROWTH FACTOR II MICRORNA BINDING PROTEIN 1; PROTEIN IMP1; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA; BIOLOGICAL PRODUCT; IMP 1 PROTEIN, HUMAN; IMP-1 PROTEIN, HUMAN; RNA BINDING PROTEIN; VIRON;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DNA PACKAGING; DOWN REGULATION; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RNA PACKAGING; RNA STABILITY; VIRION; ANIMAL; CELL LINE; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; METABOLISM; MOUSE; RAT; RETROVIRUS; VIRUS ASSEMBLY; VIRUS GENOME;

MURINE LEUKEMIA VIRUS;

ANIMALS; BIOLOGICAL PRODUCTS; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; GENOME, VIRAL; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; NIH 3T3 CELLS; RATS; RETROVIRIDAE; RNA, VIRAL; RNA-BINDING PROTEINS; VIRUS ASSEMBLY;

EID: 78650852496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015881     Document Type: Article

References (44)

1. Higashikawa F, Chang L (2001) Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280: 124-131.
2. Huang AS, Baltimore D (1970) Defective viral particles and viral disease processes. Nature 226: 325-327.
3. Pedro Lei STA (2005) Stoichiometric limitations in assembly of active recombinant retrovirus. Biotechnol Bioeng 90: 781-792.
4. Duesberg PH (1968) The RNA of influenza virus. Proc Natl Acad Sci U S A 59: 930-937.
5. Kuznetsov YG, Low A, Fan H, McPherson A (2004) Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein. Virology 323: 189-196.
6. Shields A, Witte WN, Rothenberg E, Baltimore D (1978) High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell 14: 601-609.
7. Carmo M, Alves A, Rodrigues AF, Coroadinha AS, Carrondo MJ, et al. (2009) Stabilization of gammaretroviral and lentiviral vectors: from production to gene transfer. J Gene Med 11: 670-678.
8. Coroadinha AS, Ribeiro J, Roldao A, Cruz PE, Alves PM, et al. (2006) Effect of medium sugar source on the production of retroviral vectors for gene therapy. Biotechnol Bioeng 94: 24-36.
9. Ogert RA, Lee LH, Beemon KL (1996) Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J Virol 70: 3834-3843.
10. Kotani H, Newton PB, 3rd, Zhang S, Chiang YL, Otto E, et al. (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5: 19-28.
11. McTaggart S, Al-Rubeai M (2001) Relationship between cell proliferation, cellcycle phase, and retroviral vector production in FLYRD18 human packaging cells. Biotechnol Bioeng 76: 52-60.
12. Le Doux JM, Davis HE, Morgan JR, Yarmush ML (1999) Kinetics of retrovirus production and decay. Biotechnol Bioeng 63: 654-662.
13. Shen BQ CM, Palsson BO (1996) Kinetics of retroviral production from the amphotropic YCRIP murine producer cell line Cytotechnology 22.
14. Lavillette D, Marin M, Ruggieri A, Mallet F, Cosset FL, et al. (2002) The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol 76: 6442-6452.
15. Morita S, Kojima T, Kitamura T (2000) Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1066.
16. Olsen JC, Sechelski J (1995) Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cDNA. Hum Gene Ther 6: 1195-1202.
17. Pages JC, Loux N, Farge D, Briand P, Weber A (1995) Activation of Moloney murine leukemia virus LTR enhances the titer of recombinant retrovirus in psi CRIP packaging cells. Gene Ther 2: 547-551.
18. Rodrigues T, Alves A, Lopes A, Carrondo MJ, Alves PM, et al. (2008) Removal of envelope protein-free retroviral vectors by anion-exchange chromatography to improve product quality. J Sep Sci 31: 3509-3518.
19. Levin JG, Grimley PM, Ramseur JM, Berezesky IK (1974) Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol 14: 152-161.
20. Levin JG, Rosenak MJ (1976) Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci U S A 73: 1154-1158.
21. Messer LI, Levin JG, Chattopadhyay SK (1981) Metabolism of viral RNA in murine leukemia virus-infected cells; evidence for differential stability of viral message and virion precursor RNA. J Virol 40: 683-690.
22. Paskind MP, Weinberg RA, Baltimore D (1975) Dependence of Moloney murine leukemia virus production on cell growth. Virology 67: 242-248.
23. Dorman N, Lever A (2000) Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J Virol 74: 11413-11417.
24. Flynn JA, Telesnitsky A (2006) Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology 344: 391-400.
25. Flynn JA, An W, King SR, Telesnitsky A (2004) Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol 78: 12129-12139.
26. Yisraeli JK (2005) VICKZ proteins: a multi-talented family of regulatory RNAbinding proteins. Biol Cell 97: 87-96.
27. Nielsen FC, Nielsen J, Christiansen J (2001) A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl 234: 93-99.
28. Bernstein PL, Herrick DJ, Prokipcak RD, Ross J (1992) Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev 6: 642-654.
29. Leeds P, Kren BT, Boylan JM, Betz NA, Steer CJ, et al. (1997) Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro. Oncogene 14: 1279-1286.
30. Nielsen FC, Gammeltoft S, Christiansen J (1990) Translational discrimination of mRNAs coding for human insulin-like growth factor II. J Biol Chem 265: 13431-13434.
31. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, et al. (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19: 1262-1270.
32. Gao G, Guo X, Goff SP (2002) Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297: 1703-1706.
33. Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G (2004) The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78: 12781-12787.
34. Douaisi M, Dussart S, Courcoul M, Bessou G, Vigne R, et al. (2004) HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. Biochem Biophys Res Commun 321: 566-573.
35. Butsch M, Boris-Lawrie K (2002) Destiny of unspliced retroviral RNA: ribosome and/or virion? J Virol 76: 3089-3094.
36. Zhou Y, Rong L, Lu J, Pan Q, Liang C (2008) Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. J Virol 82: 5683-5692.
37. Doyle GA, Betz NA, Leeds PF, Fleisig AJ, Prokipcak RD, et al. (1998) The cmyc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res 26: 5036-5044.
38. Lemm I, Ross J (2002) Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol 22: 3959-3969.
39. Runge S, Nielsen FC, Nielsen J, Lykke-Andersen J, Wewer UM, et al. (2000) H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein. J Biol Chem 275: 29562-29569.
40. Gao G, Goff SP (1998) Replication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides. J Virol 72: 5905-5911.
41. Telesnitsky A, Blain S, Goff SP (1995) Assays for retroviral reverse transcriptase. Methods Enzymol 262: 347-362.
42. Gao G, Goff SP (1999) Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection. Mol Biol Cell 10: 1705-1717.
43. Smith CM, Potts WB, 3rd, Smith JS, Roth MJ (1997) RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology 229: 437-446.
44. Guo X, Ma J, Sun J, Gao G (2007) The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci U S A 104: 151-156.